Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells

Endocrinology

Volumn 140, Issue 3, 1999, Pages 1399-1407

  Zheng, Jing ^a   Bird, Ian M ^a   Melsaether, Amy N ^a   Magness, Ronald R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FETOPLACENTAL UNIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP;

EID: 0032964106     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.3.6542     Document Type: Article

References (47)

1. 1. Reynolds LP, Redmer DA 1995 Utero-placental vascular development and placental function. J Anim Sci 73:1839-1851
2. 2. Magness RR, Zheng J 1996 Maternal cardiovascular alterations during pregnancy. In: Gluckman PD, Heymann MA (eds) Pediatric and Perinatal Perspectives: The Scientific Basic. Edward Arnold, London, pp 762-772
3. 3. Magness RR, Rosenfeld CR 1993 Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy. Endocrinology 132:2445-2452
4. 2 and NO in pregnancy. Am J Physiol 270:H1914-H1923
5. 5. Magness RR, Shaw CE, Phemetton TM, Zheng J, Bird IM 1997 Endothelial vasodilator production by uterine and systemic arteries II. Pregnancy effects on NO synthase expression. Am J Physiol 272:H1730-H1740
6. 6. Chang JK, Roman C, Heymann MA 1992 Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lamb in utero. Am J Obstet Gynecol 166:727-734
7. 7 Myatt L, Brewer A, Langdon G, Brockman DE 1992 Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gyneol 166:224-230
8. 8 McCarthy AL, Woolfson RG, Evans BJ, Davies DR, Raju SK, Poston L 1994 Functional characteristics of small placental arteries. Am J Obstet Gynecol 170:945-951
9. 9. Lyall F, Greer IA, Young A, Myatt L 1996 Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 17:165-168
10. 10. Boura AL, Walters WA, Read MA, Leitch IM 1994 Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 21:737-748
11. 11. Sooranna SR, Morris NH, Steer PJ 1995 Placental nitric oxide metabolism. Reprod Fertil Dev 7:1525-1531
12. 12. Schreiber AB, Winkler ME, Derynck R 1986 Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232:1250-1253
13. 13 Zheng J, Vagnoni KE, Bird IM, Magness RR 1997 Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptors in the ovine placenta during the third trimester of pregnancy. Biol Reprod 56:1189-1197
14. 14. Ferriani RA, Ahmed A, Sharkey AM, Smith SK 1994 Co-localization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 10:259-268
15. 15. Cheung CY, Singh M, Ebaugh MJ, Brace RA 1995 Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 173:753-759
16. 16. Ahmed A, Li XF, Dunk C, Whittle JM, Rushton DI, Rollason T 1995 Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243
17. 17. Cooper JC, Sharkey AM, McLaren J, Charnock-Jones DS, Smith SK 1995 Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J Reprod Fertil 105:205-213
18. 18. Kajikawa K, Yasui W, Sumiyoshi H, Yoshida K, Nakayama H, Ayhan A, Yokozaki H, Ito H, Tahara E 1991 Expression of epidermal growth factor in human tissues. Virchows Arch A Pathol Anat 418:27-32
19. 19. Varner MW, Dildy GA, Hunter C, Dudley DJ, Clark SL, Mitchell MD 1996 Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. J Soc Gynecol Invest 3:12-19
20. 20. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G 1991 Hypotensive activity of fibroblast growth factor. Science 254:1808-1810
21. 21. Ku DD, Zaleski JK, Liu S, Brock TA 1993 Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586-H592
22. 22. Kadota O, Ohta S, Kumon Y, Sakaki S, Matsuda S, Sakanaka M 1995 Role of basic fibroblast growth factor in the regulation of rat basilar artery tone in vivo. Neurosci Lett 199:99-102
23. 23. Ni Y, May V, Braas K, Osol K 1997 Pregnancy augements utero placental vascular endothelial growth factor (VEGF) gene expression and vasodilators in rat uterine circulation. Am J Physiol 273:H938-H944
24. 24. Kostyk SK, Kourembanas EL, Medeiros WD, McQuilllan LP, D'Amore PA, Braunhut SJ 1995 Basic fibroblast growth factor increases nitric synthase production in bovine endothelial cells. Am J Physiol 269:H1583-H1589
25. 25. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman, Isner JM 1997 Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
26. 26. Ahmed A, Dunk C, Kniss D, Wilkes M 1997 Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791
27. 27. Parenti A, Morbidelli L, Cui X, Douglass JG, Hood JD, Grangers HJ, Ledda F, Ziche M 1998 Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273:4220-4226
28. 28. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
29. 29. Denhardt DT 1996 Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318:729-747
30. 30. Blenis J 1993 Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90:5889-5892
31. 31. Milasincic DJ, Calera MR, Farmer SR, Pilch PF 1996 Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-5973
32. 32. Sa G, Murugesan G, Jaye M, Ivashchenko Y, Fox PL 1995 Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270:2360-2366
33. 33. Campbell JS, Wenderoth MP, Hauschka SD, Krebs EG 1995 Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells. Proc Natl Acad Sci USA 92:870-874
34. 34. D'Angelo G, Struman I, Martial J, Weiner RI 1995 Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the anti-angiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374-6378
35. 35. Zheng J, Magness RR, Bird IM 1998 A cell model for studying expression of feto-placental artery endothelial cell angiotensin II type-1 receptors and nitric oxide synthase. Med Biochem 1:57-64
36. 36. Bird IM, Zheng J, Cale JM, Magness RR 1997 Pregnancy induces an increase in angiotensin II type 1-receptor expression in uterine but not systemic artery endothelium. Endocrinology 138:490-498
37. 37. Dudley DT, Pang P, Decker SJ, Bridges AJ, Saltiel AR 1995 A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689
38. 38. Pang L, Sawada T, Decker SJ, Saltiel AR 1995 Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588
39. 39. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN 1997 Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II-and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 272:24684-24690
40. 40. Scrimgeour AG, Blakesley VA, Stannard BS, LeRoith D 1997 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis. Endocrinology 138:2552-2558
41. 41. Cale JM, Shaw CE, Bird IM 1998 Optimization of a reverse transcription-polymerase chain reaction (RT-PCR) mass assay for low-abundance mRNA. In: Bird IM (ed) Methods in Molecular Biology: Phospholipid Signaling Protocols, chapt 31. Humana Press, Totowa, vol. 105:351-371
42. 42. Millican DS, Bird IM 1997 A general method for single-stranded DNA probe generation. Anal Biochem 249:114-117
43. 43. Barone MV, Courtneidge SA 1995 Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512
44. 44. Wilkie N, Morton C, Ng LL, Boarder MR 1996 Stimulated mitogen-activated protein kinase is necessary but not sufficient for the mitogenic response to angiotensin II. A role for phospholipase D. J Biol Chem 271:32447-32453
45. 45. Ziche M, Morbidelli L, Mchoudhuri R, Zhang HT, Donnini S, Granger HJ, Aggi CA, Bicknell R 1997 Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634
46. 46. Shigeta K, Hiramatsu Y, Eguchi K, Sekiba K 1992 Urinary and plasma epidermal growth factor levels are decreased in neonates with intrauterine growth retardation and their mothers. Biol Neonate 62:76-82
47. 47. Hill DJ, Tevaarwerk TJM, Arany E, Kilkenny D, Gregory M, Langford KS, Miell J 1995 Fibroblast growth factor-2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. J Clin Endocrinol Metab 80:1822-1831